Application of Recombinant DNA Technology (RDT) in Insulin Production as Diabetes Mellitus Therapy: Systematic Literature Review
DOI:
10.29303/jbt.v26i2.11792Published:
2026-04-20Downloads
Abstract
Diabetes mellitus is known as a chronic metabolic disease characterized by impaired insulin production or function, resulting in prolonged hyperglycemia. The availability of safe, effective, and affordable insulin is crucial in managing this disease. Advances in biotechnology through the application of recombinant DNA technology (RDT) have enabled the mass production of human insulin with high purity. This literature review aims to analyze the application of recombinant DNA technology in insulin production and evaluate its contribution as a diabetes mellitus therapy. The method used was a Systematic Literature Review (SLR) of various scientific articles and relevant academic sources discussing genetic engineering processes, microorganism expression systems, and the effectiveness of recombinant insulin through the Scopus database. The results of the study indicate that the technique of inserting the human insulin gene into a plasmid vector and expressing it through microorganisms such as Escherichia coli or yeast allows the production of insulin that is structurally identical to natural human insulin. This technology improves therapeutic safety, reduces the risk of immunological reactions compared to animal-based insulin, and supports the availability of industrial-scale production. The application of recombinant DNA technology plays a significant role in the development of more effective, safe, and sustainable diabetes mellitus therapies.
Keywords:
Biotechnology Diabetes mellitus Insulin Recombinant technologyReferences
Aminuddin, A., Sima, Y., Izza, N.C., Lalla, N.S.N., & Arda, D. (2023). Edukasi Kesehatan tentang Penyakit Diabetes Melitus bagi Masyarakat. Abdimas Polsaka: Jurnal Pengabdian Kepada Masyarakat, 2(1), 7-12. https://doi.org/10.35816/abdimaspolsaka.v2i1.25
Ardandi,, R.Y., Nurhaliza, S., Poty, P.M., Sha, N.P., Himayani, R., & Rahmanisa, S. (2024). Penerapan DNA Rekombinan dalam Terapi Gen: Vaksin DNA SARS-CoV-2 dan Terapi Kanker. Medula, 14(5), 895-901. https://doi.org/10.53089/medula.v14i5.930
Asriadi, M. (2025). Synthesis Research: Pendekatan, Metode, dan Aplikasi. Gowa: CV. Ruang Tentor.
Asteria, S. C., Sipangkar, R., Rahmadela, A., & Hanifa, N. (2020). DNA rekombinan. Jakarta: Fakultas Farmasi, Institut Sains Teknologi Nasional.
Boughanem, H., Pilo, J., García-Flores, L. A., Arranz-Salas, I. M., Ramos Fernández, M., Ortega-Castan, M., Crujeiras, A. B., Sandoval, J. M., & MacÍas-González, M. (2024). Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance. Journal of Translational Medicine, 22(1). https://doi.org/10.1186/s12967-024-05329-x
Dong, W., Bai, J., Yuan, Q., Zhang, Y., Zhang, Y., Zhang, Z., Yang, M., Li, H., Zhao, Z., & Jiang, H. (2025). Mazdutide, a dual agonist targeting GLP-1R and GCGR, mitigates diabetes-associated cognitive dysfunction: mechanistic insights from multi-omics analysis. eBioMedicine, 117. https://doi.org/10.1016/j.ebiom.2025.105791
Fitriyah, C. N., & Herdiani, N. (2022). Konsumsi gula dan kebiasaan merokok dengan kejadian diabetes melitus di Puskesmas Gading Surabaya. JIK Jurnal Ilmu Kesehatan, 6(2), 467. https://doi.org/10.33757/jik.v6i2.567
GhavamiNejad, A., Liu, J. F., Mirzaie, S., Lu, B., Samarikhalaj, M., Giacca, A., & Wu, X. (2025). Catechol-based chemistry for hypoglycemia-responsive delivery of zinc-glucagon via hydrogel-based microneedle patch technology. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-58278-4
Hariawan, H., Fathoni, A., & Purnamawati, D. (2019). Hubungan gaya hidup (pola makan dan aktivitas fisik) dengan kejadian diabetes melitus di rumah sakit umum Provinsi NTB. Jurnal Keperawatan Terpadu, 1(1), 1–7. https://doi.org/10.32807/jkt.v1i1.16
Huang, Y., Lin, X., Deng, M., Tang, Y., Li, S., Xu, B., Zeng, W., Chen, Z., Hou, X., Lin, Z., Meng, X., Bai, Y., Fan, H., & Zeng, W. (2026). Oral delivery of GLP-1 analogues by recombinant Lactococcus lactis restores pancreatic islet structure through intestinal mucosal absorption in diabetic mice. eBioMedicine, 124. https://doi.org/10.1016/j.ebiom.2026.106141
Ikhrofani, S. R., Fitriani, S. A., Aurelie, A. O., & Zaki, M. R. (2021). Insulin rekombinan. Jurusan Pendidikan IPA, Fakultas Matematika dan Ilmu Pengetahuan Alam, Universitas Negeri Yogyakarta.
Jendle, J. H., & Reznik, Y. (2023). Use of insulin pumps and closed-loop systems among people living with diabetes: A narrative review of clinical and cost-effectiveness to enable access to technology and meet the needs of payers. Diabetes, Obesity and Metabolism, 25(S2), 21–32. https://doi.org/10.1111/dom.15087
Juripah, Muzakkir, H., & Darmawan, S. (2019). Hubungan pola makan terhadap kejadian diabetes melitus di wilayah kerja Puskesmas Kassi-Kassi Kota Makassar. Jurnal Ilmiah Kesehatan Diagnosis, 14, 247–252.
Lesmono, R. (2024). Definisi diabetes melitus menurut WHO. RedaSamudera.id
López-Macías, C. I. I. I. R., Torres, M., Armenta-Copca, B., Wacher-Rodarte, N. A., Castro-Castrezana, L., Colli-Domínguez, A. A., Rivera-Hernandez, T., Torres-Flores, A., Damián-Hernández, M., Ramírez-Martínez, L. A., la Rosa, G. P. de, Rojas-Martínez, O., Suárez-Martínez, A., Peralta-Sánchez, G. J., Carranza, C., Juárez, E., Zamudio Meza, H., Carreto-Binaghi, L. E., Viettri, M., … Lozano-Dubernard, B. (2025). Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX/COVID-12 “Patria” recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in Mexico. Vaccine, 43. https://doi.org/10.1016/j.vaccine.2024.126511
Lumen Learning. (n.d.) Microbes and the Tools of Genetic Engineering. https://courses.lumenlearning.com/suny-mcc-microbiology/chapter/microbes-and-the-tools-of-genetic-engineering/
Margaret, C. (2025). Pengaruh Terapi Kombinasi Insulin Basal-Bolus terhadap Kadar HbA1c pada Pasien Diabetes Mellitus Tipe 2 di RSD K.R.M.T. Wongsonegoro. Fakultas Farmasi Universitas Islam SultanAgung Semarang.
Murtiningsih, M. K., Karel, P., & Bisuk, P. S. (2021). Gaya hidup sebagai faktor risiko diabetes melitus tipe 2. Jurnal e-Clinic, 9(2), 328–333. http://dx.doi.org/10.33846/sf16310
Nasution, F., Andilala, & Siregar, A. A. (2021). Faktor risiko kejadian diabetes mellitus. Jurnal Ilmu Kesehatan, 9(2), 94–102. https://doi.org/10.32831/jik.v9i2.304
Nugrahaeni, D. K., & Danthin, A. P. (2020). Faktor risiko terjadinya diabetes mellitus tipe 2 pada wanita menopause. Jurnal Kesehatan Kartika, 15(3), 48–52. https://doi.org/10.26874/jkkes.v15i3.61
Rahmi, A. F. (2023). Rekombinan DNA produksi insulin. Access in youtube https://youtu.be/crqtghDtd1o?si=xlxXotIYVarlmoMI
Resti, H. Y., & Cahyati, W. H. (2022). Kejadian Diabetes Melitus Pada Usia Produktif Di Puskesmas Kecamatan Pasar Rebo, Kota Jakarta Timur. HIGEIA (Journal of Public Health Research and Development), 6(3), 350-361. https://doi.org/10.15294/higeia.v6i3.55268
Roselince, E. V., Awang, I. A., Pay, I. J., Poti, N. R. H., Milla, Y. S., & Hara, Y. K. (2019). Teknologi DNA rekombinan dan transgenik. Universitas Kristen Wira Wacana Sumba.
Salsabila, L., Rindarwati, A. Y., Destiani, D. P., Jumaica, P. A. (2024). Upaya Peningkatan Kesadaran Masyarakat dan Deteksi Dini Diabetes Melitus Melalui Edukasi dan Skrining. BATIK: Jurnal Pengembangan dan Pengabdian Masyarakat Multikultural, 2(2), 76-80. https://doi.org/10.57152/batik.v2i2.1577
Sarkar, Z., Sartaj, A., Nehal, N., Baboota, S., & Ali, J. (2025). Innovative approaches in insulin delivery: Exploring molecular techniques and system developments. Letters in Drug Design and Discovery, 22(7). https://doi.org/10.1016/j.lddd.2025.100103
Setiawan, P., Sinthary, V., Nasri, Nurbaiti, Iksen, Mesak, I.J., Sari, D.M., Anurogo, D., Rahayu, F.E., Wutsqa, Y.U., & Silvyana, A. E. (2022). Bioteknologi Farmasi: Infrastruktur dan Fenomena. Padang: Get Press Indonesia.
Soelistijo, S. A., Suastika, K., Lindarto, D., Decroli, E., Permana, H., Sucipto, K.W., Kusnadi, T., Budiman, Ikhsan, R., Sasiarini, L., Sanusi, H., Nugroho, H., & Susanto, H. (2024). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia.Jakarta: PB Perkeni.
Tanati, A. A. M., & Nurvita, S. (2025). Gambaran faktor-faktor penyebab terjadinya penyakit diabetes melitus di UPTD Puskesmas Kedungmundu Kota Semarang. MAHESA: Malahayati Health Student Journal, 5(6), 2632–2644. https://doi.org/10.33024/mahesa.v5i6.17279
Tandra, H. (2017). Segala sesuatu yang harus Anda ketahui tentang diabetes tipe 2. Jakarta: Gramedia Pustaka Utama.
Wu, H., Li, C., Yuan, H., Zhao, J., & Li, S. (2025). Brain Delivery Strategies for Biomacromolecular Drugs: Intranasal Administration. International Journal of Nanomedicine, 20, 6463–6487. https://doi.org/10.2147/IJN.S520768
License
Copyright (c) 2026 Marwadani Tajusman, Amelia Putri, Yusmina Hala
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
